EDIT-301 was well-tolerated and demonstrated a safety profile consistent with myeloablative conditioning with busulfan and autologous hematopoietic stem cell transplant In the RUBY trial, Patients 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results